DaviesS.J., OggC.S., CameronJ.S., PostonS., NobleW.C.Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1989; 9: 61–4.
2.
MujaisS.Microbiology and outcomes of peritonitis in North America.Kidney Int Suppl2006; (103): S55–62.
3.
Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis.Mupirocin Study Group.J Am Soc Nephrol1996; 7: 2403–8.
4.
WongS.S., ChuK.H., CheukA., TsangW.K., FungS.K., ChanH.W.Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.Perit Dial Int2003; 23(Suppl 2): S153–8.
5.
ThodisE., BhaskaranS., PasadakisP., BargmanJ.M., VasS.I., OreopoulosD.G.Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.Perit Dial Int1998; 18: 261–70.
6.
LimC.T., WongK.S., FooM.W.The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.Nephrol Dial Transplant2005; 20: 1702–6.
7.
BernardiniJ., BenderF., FlorioT., SloandJ., PalmmontalbanoL., FriedL.Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.J Am Soc Nephrol2005; 16: 539–45.
8.
ChuK.H., ChoyW.Y., CheungC.C., FungK.S., TangH.L., LeeW.A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter–related infections.Perit Dial Int2008; 28: 505–8.
9.
MahaldarA., WeiszM., KathuriaP.Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.Adv Perit Dial2009; 25: 56–9.
10.
VasS.I., ConlyJ., BargmanJ.M., OreopoulosD.G.Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients.Perit Dial Int1999; 19: 313–14.
11.
Pérez-FontánM., RosalesM., Rodríguez-CarmonaA., FalcónT.G., ValdésF.Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis.Am J Kidney Dis2002; 39: 337–41.
12.
LobbedezT., GardamM., DedierH., BurdzyD., ChuM., IzattS.Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.Nephrol Dial Transplant2004; 19: 3140–3.
13.
AnnigeriR., ConlyJ., VasS., DedierH., PrakashanK.P., BargmanJ.M.Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection.Perit Dial Int2001; 21: 554–9.
14.
LandryD.L., BradenG.L., GobeilleS.L., HaesslerS.D., VaidyaC.K., SweetS.J.Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis.Clin J Am Soc Nephrol2010; 5: 1799–804.
15.
VendittoM., du MontcelS.T., RobertJ., TrystamD., DighieroJ., HueD.Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin.Blood Purif2010; 29: 268–73.
16.
AbbasS.A., HaloobI.A., TaylorS.L., CurryE.M., KingB.B., Van der MerweW.M.Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report.Am J Kidney Dis2009; 53: 492–502.
